NCT03683498View on ClinicalTrials.gov

Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions
Chronic Graft vs Host Disease
Interventions
BIOLOGICAL

Regulatory T-cell enriched infusion

Enrichment of CD25hi regulatory T cells from CD8 and/or CD19 pre-depleted leukapheresis products.

Trial Locations (1)

41013

Hospital Universitario Virgen del Rocío, Seville

All Listed Sponsors
lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT03683498 - Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-Disease | Biotech Hunter | Biotech Hunter